Ponatinib
SPON-1751-19
Phase 2 small_molecule active
Quick answer
Ponatinib for Acute Lymphoblastic Leukemia, Adult is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Acute Lymphoblastic Leukemia, Adult
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active